Cronos Group (TSE:CRON) Sets New 12-Month High - Should You Buy?

Key Points

• Cronos Group reported a new 52-week high share price of C$3.83, with last trading at C$3.82 and a volume of 113,111 shares traded.
• The company has a market capitalization of C$1.46 billion and operates with a low debt-to-equity ratio of 0.17.
• Cronos Group specializes in cultivating and selling medicinal and recreational cannabis, with operations primarily in Canada and exports to Poland and Germany.

Cronos Group Inc. (TSE:CRON - )'s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as C$3.83 and last traded at C$3.82, with a volume of 113111 shares traded. The stock had previously closed at C$3.64.

Cronos Group Stock Performance

The business's 50-day moving average price is C$3.28 and its 200-day moving average price is C$2.86. The company has a current ratio of 24.24, a quick ratio of 24.01 and a debt-to-equity ratio of 0.17. The stock has a market cap of C$1.46 billion, a PE ratio of 76.20, a P/E/G ratio of 0.12 and a beta of 1.21.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.